Fibroblast growth factors in Alzheimer’s Disease pathogenesis: neuropharmacological implications for neuroprotection, neurogenesis, and therapeutic development
FGF signalling is positioned as a promising yet underexplored neuropharmacological axis for developing disease-modifying strategies in Alzheimer’s disease and the therapeutic potential and challenges of targeting FGF signalling are evaluated.